| Q47548456 | A case of herpes simplex virus pneumonia detected by sputum cytodiagnosis |
| Q38049752 | A review of common oral pathology lesions, with a focus on periodontology and implantology |
| Q72043021 | A study of HLA and DRw antigens in severe recurrent herpes progenitalis (HSV-2) infection |
| Q40421884 | Activation of c-Jun N-terminal kinase (JNK) pathway by HSV-1 immediate early protein ICP0. |
| Q33583052 | Acyclovir in first attacks of genital herpes and prevention of recurrences |
| Q43798277 | Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients |
| Q36465468 | Alteration of Mortality and Pathogenesis of Three Experimental Herpesvirus hominis Infections of Mice with Adenine Arabinoside 5′-Monophosphate, Adenine Arabinoside, and Phosphonoacetic Acid |
| Q28373156 | Anti-herpes simplex virus activities of crude water extracts of Thai medicinal plants |
| Q35114805 | Antibodies to Herpesvirus hominis types 1 and 2 in malnourished Nigerian children |
| Q41130557 | Association between development of lower lip cancer and tobacco habits |
| Q45767511 | Attenuation of the natural course of herpes simplex virus infection in human oral epithelial cell cultures by smokeless tobacco extracts suggests the possibility of a synergistic mechanism for carcinogenesis |
| Q33387016 | Atypical herpesvirus hominis type 2 infection in uremic patients receiving immunosuppressive therapy |
| Q39918321 | Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells |
| Q34460442 | Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitis |
| Q42938618 | Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88. |
| Q40295193 | Chorioretinitis of the newborn with herpes simplex virus type 1. Report of a case |
| Q39927563 | Clinically distinguishable syndromes caused by viruses |
| Q45847765 | Cloned bovine cytolytic T cells recognize bovine herpes virus-1 in a genetically restricted, antigen-specific manner |
| Q45805848 | Comparative study of the sensitivity of herpes simplex virus types 1 and 2 to human leukocyte interferon in vitro |
| Q40216216 | Comparison of Cultureset to a Conventional Tissue Culture—Fluorescent-Antibody Technique for Isolation and Identification of Herpes Simplex Virus |
| Q55194751 | Cytomegalovirus infection associated with lower urinary tract symptoms |
| Q72853641 | DNA fingerprinting in investigation of apparent nosocomial acquisition of neonatal herpes simplex |
| Q40117038 | Depressed herpes simplex virus-induced lymphocyte blastogenesis in individuals with severe recurrent herpes infections |
| Q37224689 | Detection of asymptomatic initial herpes simplex virus (HSV) infections in animals immunized with subunit HSV glycoprotein vaccines |
| Q37302802 | Detection of genital herpes simplex infections by a tissue culture-fluorescent-antibody technique with biotin-avidin. |
| Q53752583 | Disseminated herpes simplex infection in a newborn--treatment with acyclovir. |
| Q40501688 | Disseminated herpes simplex with hepatoadrenal necrosis in a child with acute leukemia |
| Q40626329 | Eczema herpeticum: Atopic dermatitis complicated by primary herpetic gingivostomatitis |
| Q45800074 | Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig |
| Q33898085 | Effect of prostaglandins and cyclic adenosine 3',5'-monophosphate modulators on herpes simplex virus growth and interferon response in human cells |
| Q33723014 | Effect of treatment with 1-beta-D-arabinofuranosylthymine of experimental encephalitis induced by herpes simplex virus in mice |
| Q45890915 | Effect of trisodium phosphonoformate in genital infection of female guinea pigs with herpes simplex virus type 2 |
| Q40072940 | Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice |
| Q37160936 | Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals |
| Q38032820 | Epstein-Barr virus: Structure of the viral DNA and analysis of viral RNA in infected cells |
| Q37673103 | Escape of herpesviruses from the nucleus |
| Q45846321 | Establishment of latent ganglionic infection with herpes simplex virus via maxillary gingiva and viral re-activation in vivo after trauma |
| Q45757780 | Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections |
| Q38483200 | Experimental encephalitis in the newborn rat due to herpes simplex virus type 2 |
| Q40033132 | Experimental herpes simplex virus carditis in mice |
| Q72915021 | Experimental studies of carcinogenesis of the uterine cervix in mice |
| Q45802997 | Fatal herpes simplex encephalitis with demonstration of virus in the olfactory pathway |
| Q35528603 | First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology |
| Q67315750 | Genital herpes and cervical carcinoma |
| Q45797926 | Genital infection with herpes simplex virus type 1 |
| Q37110823 | HLA-restricted T lymphocyte-mediated cytotoxicity against herpes simplex virus-infected cells in humans |
| Q40103315 | Herpes simplex encephalitis: an autopsy case with isolation of type 1 herpes simplex virus |
| Q70105282 | Herpes simplex viral infection in human neonates: an immunohistochemical and electron microscopic study |
| Q70186191 | Herpes simplex viral pneumonitis in childhood |
| Q77304582 | Herpes simplex virus |
| Q36865265 | Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus |
| Q55644884 | Herpes simplex virus and Guillain-Barre polyradiculitis |
| Q45710006 | Herpes simplex virus in the respiratory tract of critical care patients: a prospective study |
| Q37571758 | Herpes simplex virus latency in isolated human neurons |
| Q35044114 | Herpes simplex virus type 1 and bovine herpesvirus 1 latency |
| Q41532313 | Herpes simplex virus types 1 and 2 and multiple sclerosis |
| Q45842445 | Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization |
| Q37976790 | Herpes simplex viruses 1 and 2—basic and clinical aspects |
| Q40837372 | Herpes type 2 infection with unusual generalised manifestations and delayed diagnosis in an adult male |
| Q40590036 | Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes. |
| Q40269874 | Herpesvirus hominis Type 1: A summary of structure, composition, growth cycle, and cytopathogenic effects |
| Q33656266 | Herpesvirus hominis antibodies among children and young adults in Ibadan |
| Q34927859 | Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine |
| Q33657169 | Herpesvirus hominis type 2 infection in Ibadan. Problem of non-venereal transmission |
| Q40024577 | Herpesvirus hominis type 2 meningoencephalitis following renal transplantation |
| Q45800317 | Herpetic tracheobronchitis: Immunohistologic demonstration of herpes simplex virus antigen |
| Q34720319 | Herpetic whitlow: herpetic infections of the digits |
| Q33922876 | Identification of a novel herpes simplex virus type 1 transcript and protein (AL3) expressed during latency. |
| Q39736685 | Identification of herpes simplex virus type 1 proteins encoded within the first 1.5 kb of the latency-associated transcript |
| Q40008925 | Identification of two small RNAs within the first 1.5-kb of the herpes simplex virus type 1-encoded latency-associated transcript |
| Q39945927 | Idiopathic Facial Paralysis, Pregnancy, and the Menstrual Cycle |
| Q40072292 | IgG-, IgA- and IgM-antibodies to herpes simplex virus type 2 in sera from patients with cancer of the uterine cervix |
| Q40023597 | Immunology of herpesvirus infection: Immunity to herpes simplex virus in eye infections |
| Q34585480 | Increased incidence of skin infections in atopy: evidence for an antigen-specific homing defect? |
| Q36341079 | Kinetics and genetics of herpes simplex virus-induced antibody formation in mice |
| Q37699098 | Large Amounts of Reactivated Virus in Tears Precedes Recurrent Herpes Stromal Keratitis in Stressed Rabbits Latently Infected with Herpes Simplex Virus |
| Q39934802 | Latent Infection of Sensory Ganglia with Herpes Simplex Virus: Efficacy of Immunization |
| Q40156772 | Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site |
| Q35884349 | Latent herpes simplex virus type 1 gene expression in ganglia innervating the human gastrointestinal tract. |
| Q38480592 | Leptomeningitis and polycaryocyte formation in the CNS of rats inoculated subcutaneously with herpes simplex virus |
| Q70029220 | Letter: A new molecular defect in phenylketonuria |
| Q45826354 | Letter: Herpes-simplex virus (type 1) transmitted to a neonate |
| Q37717049 | Liver disease in renal transplant recipients |
| Q71144691 | Long-term management of a patient with vitamin B12-responsive methylmalonic acidemia |
| Q37120677 | Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice |
| Q45800034 | Lymphocyte responses to herpes simplex virus isolates from patients with primary and recurrent herpes simplex genitalis |
| Q40068859 | Microbial infections in hospitals: A review of the literature and some suggestions for nursing research |
| Q70235875 | Neonatal herpes simplex virus infections |
| Q45889263 | Neurological infections caused by herpes simplex virus in adults |
| Q45733124 | Oligodendrocytes from human donors differ in resistance to herpes simplex virus 1 (HSV-1). |
| Q39874830 | Oral inoculation with herpes simplex virus type 1 infects enteric neuron and mucosal nerve fibers within the gastrointestinal tract in mice |
| Q44307449 | Pediatric herpetic hand infections |
| Q45801066 | Perinatal Herpes virus infection: report of a case indicating the paternal role |
| Q40903260 | Perinatal herpesvirus infections. Herpes simplex, varicella, and cytomegalovirus |
| Q37863226 | Persistence in herpes simplex virus infections |
| Q39997583 | Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice |
| Q38933575 | Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil |
| Q34958709 | Prospective Double-Blind Evaluation of Topical Adenine Arabinoside in Male Herpes Progenitalis |
| Q34410407 | Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine |
| Q45805645 | Protective effects of interferon, various anti-viral drugs and combinations of these on Herpes simplex virus infection in mice |
| Q36704646 | Radiculomyelopathy associated with herpes simplex genitalis treated with adenosine arabinoside |
| Q70823480 | Recommendations for pregnant employee interaction with patients having communicable infectious diseases |
| Q40611710 | Recovery of mice from herpes simplex virus type 2 hepatitis: adoptive transfer of recovery with immune spleen cells |
| Q40111282 | Relation of Herpes Simplex Viruses to Human Malignancies |
| Q33656174 | Relative and seasonal incidences of the sexually transmitted diseases. A two-year statistical review |
| Q24680651 | Replication-initiator protein (UL9) of the herpes simplex virus 1 binds NFB42 and is degraded via the ubiquitin-proteasome pathway |
| Q44137396 | Reye syndrome complicated by a generalized herpes simplex type I infection |
| Q34123889 | Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection |
| Q33900303 | Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus |
| Q40612792 | Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. |
| Q33897914 | Serum antibodies to herpes simplex virus type 1 during active oral herpes infection |
| Q40214440 | Simultaneous infection with multiple herpesviruses |
| Q35663693 | Social support and socioeconomic status interact to predict Epstein-Barr virus latency in women awaiting diagnosis or newly diagnosed with breast cancer. |
| Q72885353 | Successful treatment with acyclovir of an immunodeficient patient infected simultaneously with multiple herpesviruses |
| Q72901127 | Surgery of the nerves of the neck, nose, and ear region (except Nn. stato-acusticus and olfactorius) (author's transl) |
| Q42688553 | The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes |
| Q40203992 | The Molecular Epidemiology of Herpes Simplex Viruses |
| Q40023571 | The biology of herpes simplex virus infection in humans |
| Q33934554 | The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. |
| Q34123978 | The herpes simplex virus type 1 locus that encodes the latency-associated transcript enhances the frequency of encephalitis in male BALB/c mice |
| Q67241180 | The incidence and outcome of asymptomatic herpes simplex genitalis in an obstetric population |
| Q44922927 | The latest in herpes simplex keratitis therapy |
| Q33780491 | The locus encompassing the latency-associated transcript of herpes simplex virus type 1 interferes with and delays interferon expression in productively infected neuroblastoma cells and trigeminal Ganglia of acutely infected mice. |
| Q35048616 | The modulation of phosphatase expression impacts the proliferation efficiency of HSV-1 in infected astrocytes |
| Q37356339 | The neural F-box protein NFB42 mediates the nuclear export of the herpes simplex virus type 1 replication initiator protein (UL9 protein) after viral infection |
| Q45832562 | The role of an immunoperoxidase technique in the diagnosis of oral herpes simplex virus infection in patients with leukemia |
| Q38034239 | The role of cellular immunity in the infection with herpes simplex virus |
| Q40841217 | The use of water-soluble bioflavonoid-ascorbic acid complex in the treatment of recurrent herpes labialis |
| Q36480860 | Therapy of Experimental Herpes Simplex Encephalitis with Aciclovir in Mice |
| Q33654414 | Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle |
| Q37207155 | Two outbreaks of herpes simplex virus type 1 nosocomial infection among newborns |
| Q37333965 | Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis |
| Q37343998 | Use of biological characteristics to type Herpesvirus hominis types 1 and 2 in diagnostic laboratories |
| Q40045633 | Viral-specific humoral immunity to herpes simplex-induced antigens in patients with squamous carcinoma of the head and neck |
| Q70339959 | Women's health: Problems and options. An overview |
| Q37102567 | X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon production |